A defense neurology expert testified Thursday in the third Risperdal gynecomastia trial about the benefits and risks associated with prescribing the drug to children suffering from Tourette syndrome.
Dr. Lawrence Brown, who practices pediatric neurology at the Children’s Hospital of Pennsylvania, told jurors about the circumstances under which he prescribes Risperdal and other antipsychotics, as well as the wisdom of plaintiff Tim Stange’s doctor’s prescription of the drug.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
